Trv Gp V, LLC

Concentrated strategyQuality / disciplined sizingLong-term holder

Total reported value

$401.0M

Reporting period: 2026-03-31 · Number of holdings: 3

TRV GP V, LLC disclosed 3 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $401.0M and a quarterly turnover rate of 10.1%.

Browse other institutions with $100M to $1B AUM Browse other institutions starting with "T"

Personality snowflake

Concentration: 100
Portfolio Stability: 10.05
Momentum/Contrarian: 50
Sector conviction: 0
Diversification: 6
Sizing Uniformity: 92.64

Recent moves

Add RAPP
0.0%　$6.8M
Trim SEPN
0.0%　-$23.9M
Trim MAZE
0.0%　-$11.0M

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

#	Ticker	Issuer	Asset Subclass	Weight	Weight Change	Shares Change
1	RAPP	Rapport Therapeutics INC	Stock-Other	55.68%	+5.24%	—
2	SEPN	Septerna INC	Stock-Other	37.25%	-3.13%	—
3	MAZE	Maze Therapeutics INC	Stock-Other	7.08%	-2.10%	—

Reported value over time

Sector allocation

Not enough sector-mapped data yet

Sector allocation over time

Quarterly history

Period	Holdings	Total value	Stability	Top holdings
2026-03-31	3	$401.0M	10	1RAPP 2SEPN 3MAZE Top holdings2026-03-31 1.RAPP 2.SEPN 3.MAZE
2025-12-31	3	$429.2M	19	1RAPP 2SEPN 3MAZE Top holdings2025-12-31 1.RAPP 2.SEPN 3.MAZE
2025-09-30	3	$353.5M	93	1RAPP 2SEPN 3MAZE Top holdings2025-09-30 1.RAPP 2.SEPN 3.MAZE
2025-06-30	4	$165.7M	0	1RAPP 2SEPN 3MAZE Top holdings2025-06-30 1.RAPP 2.SEPN 3.MAZE 4.CRGX
2025-03-31	4	$125.1M	0	1RAPP 2SEPN 3MAZE Top holdings2025-03-31 1.RAPP 2.SEPN 3.MAZE 4.CRGX
2024-12-31	3	$294.0M	0	1SEPN 2RAPP 3CRGX Top holdings2024-12-31 1.SEPN 2.RAPP 3.CRGX

Holding changes this quarter

Position changes disclosed by Trv Gp V, LLC for the quarter ending 2026-03-31, including ticker, issuer, weight change, shares change, and action
#	Ticker	Issuer	Weight Change	Shares Change	Action
1	RAPP	Rapport Therapeutics INC	+5.2%	—	Unchanged
2	MAZE	Maze Therapeutics INC	-2.1%	—	Unchanged
3	SEPN	Septerna INC	-3.1%	—	Unchanged

FAQ

What is Trv Gp V, LLC and what type of investor is it?

Trv Gp V, LLC is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2026-03-31), the firm manages a tracked equity portfolio valued at approximately $401.0M, spread across 3 disclosed positions.

What are Trv Gp V, LLC's largest equity positions?

Based on the latest 13F filing, Trv Gp V, LLC's top holdings by market value are: 1. Rapport Therapeutics INC (RAPP) — $223.3M (55.7%) 2. Septerna INC (SEPN) — $149.4M (37.3%) 3. Maze Therapeutics INC (MAZE) — $28.4M (7.1%)

What changes did Trv Gp V, LLC make in its most recent portfolio filing?

No notable portfolio changes were recorded for Trv Gp V, LLC in the most recent quarter. Holdings appear to have remained relatively stable.

What sectors does Trv Gp V, LLC focus on?

Sector breakdown data is not yet available for Trv Gp V, LLC. Check back after the next 13F processing cycle.